Grimes & Company’s X4 Pharmaceuticals XFOR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-500	Closed	-$20.9K	–	360
2024 Q1	$20.9K	Hold	500	–	–	﹤0.01%	342
2023 Q4	$12.6K	Hold	500	–	–	﹤0.01%	330
2023 Q3	$16.4K	Hold	500	–	–	﹤0.01%	305
2023 Q2	$29.1K	Buy	+500	New	+$29.1K	﹤0.01%	303